Research Institute of the McGill University Health Centre
Research Institute of the McGill University Health Centre
About

The Research Institute of the McGill University Health Centre (RI-MUHC) is a world-renowned biomedical and hospital research centre. Located in Montreal, Quebec, the Institute is the research arm of the McGill University Health Centre affiliated with the Faculty of Medicine at McGill University. The Research Institute offers a dynamic multidisciplinary research environment that fosters collaboration and leverages discovery aimed at improving the health of individual patients across their lifespan.

The RI-MUHC was built to facilitate investigator-initiated and discovery-driven research that creates new knowledge in healthcare research along the whole spectrum of investigative activities. This involves fundamental biomedical research, patient-oriented and applied clinical research, research on health services and health systems, as well as population and health promotion research, including societal and cultural effects on health.

In 1997, five McGill teaching hospitals (the Montreal General (MGH est. 1821), the Royal Victoria (RVH est. 1893), the Montreal Children's (MCH est. 1904), the Montreal Chest Institute (MCI est. 1909) and the Montreal Neurological Hospital/Institute (MNH/I est. 1934) merged to form the MUHC. The RI-MUHC, created from the five hospital research institutes, became the clinical and translational research hub of the MUHC. This institute is a powerhouse, with over 440 investigators and over 1,200 students and fellows studying a wide range of health issues that affect humankind through fundamental, clinical and evaluative research. Our greatest strengths are our people, our partners and our community.

Vision

- bridge the gap between biomedical research and clinical medicine
- speed up innovation and accelerate the translation of basic discoveries to public uses
- bring together pediatric and adult research programs
- focus on improving the health of individual patients throughout their life cycle
- set the stage for the transition to patient-centred medicine

Mission

The mission of the RI-MUHC is to generate and leverage discovery and innovation to establish the MUHC as a world-class centre of excellence in patient-centred medicine. Excellence in clinical, evaluative and fundamental research will bring the innovations that will transform health care, providing an integrated view of disease and patient information with related therapies.

The primary objective of our research is to ensure that the MUHC builds on its strengths as a leader in patient-centred, innovative healthcare research, setting the stage for the transition to patient-centred medicine, an approach which focuses on the successful care and treatment of the individual patient across their life span. Laying the foundation for patient-centred medicine involves the integration of research findings, advanced technologies, and clinical data to transform existing medical practices.

This interaction will have a major positive impact on disease outcomes and lead to innovations that will form the basis of the next generation of biopharmaceutical applications, benefiting Canadians and people around the world.

Read more

Type of organization

1 office
1997
Similar organizations

Experience

Contract Awards
To Finish the Sildenafil Study
Bill & Melinda Gates Foundation (B&MGF)
To Support Capacity Building for TB Diagnostics
Bill & Melinda Gates Foundation (B&MGF)
Covid Impact on Private Health Markets
Bill & Melinda Gates Foundation (B&MGF)
Beta-Glucan Induced Trained Innate Immunity
Bill & Melinda Gates Foundation (B&MGF)
Tuberculosis Trials Consortium Services
United States Department of Health & Human Services (DHHS)
Tuberculosis Trials Consortium Services (Benin)
Centers for Disease Control and Prevention (CDC) - United States, United States Department of Health & Human Services (DHHS)

Company Offices

  • Canada (headquarters)
  • Montreal
  • 2155 Guy Street, Suite 500 Montreal, QC H3H 2R9